MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.

This study is ongoing, but not recruiting participants.
Information provided by Hoffmann-La Roche

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Non-Hodgkin's Lymphoma
2		Additional conditions recognized in this trial
			Lymphoma
			Lymphoma, Follicular
			Lymphoma, Non-Hodgkin
3		More general conditions related to this trial
			Immune System Diseases
			Immunoproliferative Disorders
			Lymphatic Diseases
			Lymphoproliferative Disorders
			Neoplasms
			Neoplasms by Histologic Type
4		Interventions listed in this trial
			rituximab [MabThera/Rituxan]
5		Additional drug interventions recognized in this trial
			Rituximab
6		More general drug interventions related to this trial
			Antineoplastic Agents
			Antirheumatic Agents
			Immunologic Factors
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
7		Sponsors listed in this trial
			Hoffmann-La Roche